Your current location: https://mountaintrike.ms-stage.co.uk/cpresources/twentytwentyfive/>go go 777

999 jili games 04

2025-01-08go go 777 编辑:999 jili games 04


999 jili games 04
999 jili games 04 Quanterix Announces Receipt of Expected Notice from NasdaqNone

RICHARDSON, TX / ACCESSWIRE / December 11, 2024 / Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and worldwide military and commercial applications, announced today it has been awarded a three-year, Indefinite Delivery Indefinite Quantity (IDIQ) contract for Optically Improved Periscopes from DLA Land and Marine with a maximum value of $6.5 million and two additional option years. Danny Schoening, CEO, Optex Systems stated "Optex continues to support our domestic armored vehicle manufactures through the ongoing supply of laser protected periscopes. These units provide our customers with real-time situational awareness while protecting them from harmful laser strikes. This three year contract speaks to the decades-long relationship with the U.S. Government and our commitment to quality and reliability." With this order, the current Optex backlog is in excess of $42 million. ABOUT OPTEX SYSTEMS Optex, which was founded in 1987, is a Richardson, Texas based ISO 9001:2015 certified concern, which manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles, and have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For additional information, please visit the Company's website at www.optexsys.com . Safe Harbor Statement This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the products and services described herein. You can identify these statements by the use of the words "may," "will," "could," "should," "would," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," "likely," "forecast," "probable," and similar expressions. These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding growth strategy; product and development programs; financial performance and financial condition (including revenue, net income, profit margins and working capital); orders and backlog; the estimated value of IDIQ contracts; expected timing of contract deliveries to customers and corresponding revenue recognition; increases in the cost of materials and labor; costs remaining to fulfill contracts; contract loss reserves; labor shortages; follow-on orders; supply chain challenges; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations; and the economy in general or the future of the defense industry. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, continued funding of defense programs and military spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company's markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in the U.S. Government's interpretation of federal procurement rules and regulations, changes in spending due to policy changes in any new federal presidential administration, market acceptance of the Company's products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, increases in tax rates, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, unanticipated costs under fixed-price service and system integration engagements, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control. You must carefully consider any such statement and should understand that many factors could cause actual results to differ from the Company's forward-looking statements. These factors include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially. The Company does not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in the Company's filings with the SEC, especially on Forms 10-K, 10-Q and 8-K. In various filings the Company has identified important factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties. Contact: IR@optexsys.com (972) 764-5718 SOURCE: Optex Systems Holdings, Inc. View the original on accesswire.com Copyright 2024 ACCESSWIRE. All Rights Reserved.It's all eyes on artificial intelligence PC demand and tariffs for HP Inc. ( HPQ ) CEO Enrique Lores entering 2025. "Some of that [cost of potential tariffs] will have to go to consumers given what is the overall margin that we have in the categories. But again, we need to wait and see what the final tariffs are for us to define what the exact plan is going to be," Lores told Yahoo Finance on Tuesday (video above). The comments on prices to consumers echo some of those made by Best Buy CEO Corie Barry today on her call with reporters. Lores said he is looking forward to working with the incoming Trump administration and prefers smooth trading relationships between countries. "We are a global company that does business in many parts of the globe, and that does development in many parts of the globe, and that has manufacturing in many parts of the globe. So for us, an easy way of trading across countries is the preferred option," Lores added. Read more: How do tariffs work, and who really pays them? As tariff convos whipsaw markets, HP released mixed fiscal fourth quarter sales results after the market close. Sales of consumer PCs fell 4% in the quarter, while commercial sales improved 5%. Operating margins in the PC division fell sharply year over year. Similar to the previous quarter, commercial clients are upgrading their computers ahead of Microsoft ( MSFT ) ending support for Windows 10 in October 2025. Consumer PCs are under slight pressure as people await new AI computer releases and spend more money on experiences. Worldwide shipments of traditional PCs in the calendar year third quarter hit 68.8 million, down 2.4% year over year, according to data from IDC . Sales were hurt by rising costs and inventory replenishment in the prior quarter, IDC explained. Net sales: $14.1 billion (+1.7% year over year) vs. $13.9 billion estimate Personal systems sales: $9.6 billion (+2% year over year) vs. $9.7 billion estimate Consumer personal system sales: -4% Commercial personal system sales: +5% Printing sales: $4.5 billion (+1% year over year) vs. $4.2 billion estimate Consumer printing sales: +3% Commercial printing sales: -1% Diluted earnings per share (EPS): $0.93 (+3% year over year) vs. $0.93 estimate (guidance: $0.89-$0.99) Weak margins: Quarterly operating margins dropped to 8.5% from 9% a year ago Personal systems operating margins fell to 5.7% from 6.7% a year ago Printing operating margins rose to 19.6% from 18.9% a year ago Fiscal first quarter EPS guidance: $0.70 to $0.76 vs. $0.86 estimate Full-year EPS guidance: $3.45 to $3.75 vs. $3.60 estimate "Demand, without a doubt, has returned for PCs amongst consumers and commercial buyers," IDC research manager Jitesh Ubrani said. "However, much of the demand was still concentrated at the entry-level thanks to a recovering economy and the back-to-school season in North America. That said, newer AI PCs such as Copilot+ PCs from Qualcomm along with Intel and AMD's equivalent chips as well as Apple's expected M4-based Macs are expected to drive the premium segment in coming months." Where HP surprised favorably for the first time in a while was its printing business. Printing sales rose 1% from the prior year and came in ahead of expectations. The upside could stem from struggles at rival Xerox ( XRX ), which is smack in the middle of deep restructuring that pros say is causing market share loss. "On print, results from peers such as Xerox came in below expectations, with Xerox's printing equipment sales declining double-digits year over year due in part to an increase in competitive activity in certain markets," Evercore ISI analyst Amit Daryanani said in a client note. Lores said HP is "gaining share" in the printing business, though declined to call out Xerox and cautioned the industry remains volatile. "We think that the overall print market in 2025 will slightly decline. The decline will be less than what we saw this year, but our goal continues to be to perform better than the market," Lores said. Brian Sozzi is Yahoo Finance's Executive Editor. Follow Sozzi on X @BrianSozzi and on LinkedIn . Tips on deals, mergers, activist situations, or anything else? Email brian.sozzi@yahoofinance.com. Click here for the latest technology news that will impact the stock market Read the latest financial and business news from Yahoo Finance



The world according to Jim: • The Commissioner of Baseball seems to have gotten out over his skis. Whether it was boredom, a desperate attempt to placate the game’s TV benefactors or a sincere desire to make the game better – and we’ll leave that for you to judge – the latest “innovation” he offered this week has to be a non-starter. • His brainstorm? The “golden at-bat.” Basically, allowing a team to use its best hitter, out of order, in a singular key situation, to artificially create a dramatic matchup. Maybe it was the Shohei Ohtani-Mike Trout confrontation at the end of the USA-Japan final in the World Baseball Classic two years ago. Or maybe it really was a TV executive, or a member of MLB’s crack marketing staff (sarcasm intended), who floated this test balloon. Time to ground it. ... • Classic confrontations can’t, and shouldn’t, be manufactured. That goes against not only the charm of baseball but the entire nature of the game. The great matchups and great late moments of the past happened organically. Gibson vs. Eckersley . in Game 1 in 1988. Bill Mazeroski vs. Ralph Terry on the final at-bat of the 1960 World Series. Or Joe Carter taking Mitch Williams deep for a Game 6 walkoff that decided the 1993 Series. Or, yes, Freddie Freeman vs. Nestor Cortes, in Game 1 of the 2024 World Series. And this is a reminder that one manager does have control over such matchups, and the Yankees’ Aaron Boone isn’t living this one down for a while. Yankees fans do have long memories. (See below.) ... • If those matchups are artificially obtained rather than organic, how long before we become bored and start referring to them as “tin can at-bats?” Then again, to Manfred one piece of metal must be no different from another. ... • Are Yankees fans jaded? You judge. The night the Dodgers won Game 5 in Yankee Stadium, Dodgers fans were still on the field and in the stands celebrating as 2 a.m. Eastern time approached . (And for others, the subway platform was party central that night.) Anyway, walking out of the ballpark after filing for West Coast deadlines, I informed the security guy at the media gate that there were still hundreds of Dodger fans celebrating inside the ballpark, two hours or so after the game had ended. His response: “Well, we still have 27 of them,” meaning championships. I didn’t remind him that his team’s drought was now 15 seasons. ... • There have been just three equal or longer droughts in Yankees history. Can you name them? Answer below. ... • So why are we reminiscing about the World Series? Have you seen the Lakers play recently? ... • The late Chick Hearn used to have a line that would pretty well alert you that things weren’t going well, even if you were listening to the radio half of the simulcast. “The Lakers are STANDING, “ he would say in a scolding, cranky grandpa tone. (And before you interpret that as a criticism, it’s not. I’ve used that tone.) Maybe John Ireland and Mychal Thompson on radio and Bill Macdonald and Stu Lantz on TV should resurrect it. ... • It’s bad enough when the Lakers stand around offensively. JJ Redick let it be known the other night that his team needed to get back to ball and player movement, and that’s sort of a basketball fundamental. But when you’re standing around on defense – or worse, taking your own sweet time getting back downcourt – that’s trouble. ... • It’s obvious that Father Time – who remains undefeated, by the way – is taking his toll on LeBron James. The goal of playing all 82 games, which James set before the season began, seems counterproductive at this point. ... • And there is a wrinkle in the league’s player participation rules, established last year and designed to make sure the stars are on the floor, especially in nationally televised games. A player who is over 35 or has more than 34,000 regular-season minutes or 1,000 regular-season and playoff games can sit out one game of a back-to-back, though it has to be preapproved by the league. If Adam Silver’s office needs convincing, I’m sure the Lakers’ video people can put together plenty of clips of James coasting back up the court. ... • Things that make you shake your head: The A’s signed free-agent pitcher Luis Severino, three years at $67 million, the largest contract in franchise history. It would serve them right if he bails on them before they get to Las Vegas in 2028 (or thereabouts). ... • Quiz answer: The Yankees have gone 19 years without winning a World Series (at the start of the franchise’s existence, 1903-23), 18 years (1978-95) and 14 years (1962-76). Otherwise, their fans don’t have that much to complain about. ... • The hubbub over college football winners planting the flag on the turf of the losers reached its nadir with a set of skirmishes last weekend, including a brawl in Columbus, Ohio, that had the cops using pepper spray to try to calm things down between Michigan and Ohio State. This may be simplistic – and there are some coaches, including Penn State’s James Franklin and Texas’ Steve Sarkisian, who have shown they can defuse such situations before they ignite – but how about this solution: Play better, and if you lose, own it. ... jalexander@scng.com

NEW YORK (AP) — President-elect Donald Trump’s lawyers formally asked a judge Monday to throw out his hush money criminal conviction , arguing that continuing the case would present unconstitutional “disruptions to the institution of the Presidency.“ In a filing made public Tuesday, Trump’s lawyers told Manhattan Judge Juan M. Merchan that anything short of immediate dismissal would undermine the transition of power, as well as the “overwhelming national mandate" granted to Trump by voters last month. They also cited President Joe Biden’s recent pardon of his son, Hunter Biden, who had been convicted of tax and gun charges . “President Biden asserted that his son was ‘selectively, and unfairly, prosecuted,’ and ‘treated differently,’" Trump’s legal team wrote. Manhattan District Attorney Alvin Bragg, they claimed, had engaged in the type of political theater "that President Biden condemned.” Prosecutors will have until Dec. 9 to respond. They have said they will fight any efforts to dismiss the case but have indicated a willingness to delay the sentencing until after Trump’s second term ends in 2029. In their filing Monday, Trump's attorneys dismissed the idea of holding off sentencing until Trump is out of office as a “ridiculous suggestion.” Following Trump’s election victory last month, Merchan halted proceedings and indefinitely postponed his sentencing, previously scheduled for late November, to allow the defense and prosecution to weigh in on the future of the case. He also delayed a decision on Trump’s prior bid to dismiss the case on immunity grounds. Trump has been fighting for months to reverse his conviction on 34 counts of falsifying business records to conceal a $130,000 payment to porn actor Stormy Daniels to suppress her claim that they had sex a decade earlier. He says they did not and denies any wrongdoing. The defense filing was signed by Trump lawyers Todd Blanche and Emil Bove, who represented Trump during the trial and have since been selected by the president-elect to fill senior roles at the Justice Department. Taking a swipe at Bragg and New York City, as Trump often did throughout the trial, the filing argues that dismissal would also benefit the public by giving him and “the numerous prosecutors assigned to this case a renewed opportunity to put an end to deteriorating conditions in the City and to protect its residents from violent crime.” Clearing Trump, the lawyers added, would also allow him to “to devote all of his energy to protecting the Nation.” Merchan hasn’t yet set a timetable for a decision. He could decide to uphold the verdict and proceed to sentencing, delay the case until Trump leaves office, wait until a federal appeals court rules on Trump’s parallel effort to get the case moved out of state court or choose some other option. An outright dismissal of the New York case would further lift a legal cloud that at one point carried the prospect of derailing Trump’s political future. Last week, special counsel Jack Smith told courts that he was withdrawing both federal cases against Trump — one charging him with hoarding classified documents at his Florida estate, the other with scheming to overturn the 2020 presidential election he lost — citing longstanding Justice Department policy that shields a president from indictment while in office. The hush money case was the only one of Trump’s four criminal indictments to go to trial, resulting in a historic verdict that made him the first former president to be convicted of a crime. Prosecutors had cast the payout as part of a Trump-driven effort to keep voters from hearing salacious stories about him. Trump’s then-lawyer Michael Cohen paid Daniels. Trump later reimbursed him, and Trump’s company logged the reimbursements as legal expenses — concealing what they really were, prosecutors alleged. Trump has said the payments to Cohen were properly categorized as legal expenses for legal work. A month after the verdict, the Supreme Court ruled that ex-presidents can’t be prosecuted for official acts — things they did in the course of running the country — and that prosecutors can’t cite those actions to bolster a case centered on purely personal, unofficial conduct. Trump’s lawyers cited the ruling to argue that the hush money jury got some improper evidence, such as Trump’s presidential financial disclosure form, testimony from some White House aides and social media posts made during his first term. Prosecutors disagreed and said the evidence in question was only “a sliver” of their case. If the verdict stands and the case proceeds to sentencing, Trump’s punishments would range from a fine to probation to up to four years in prison — but it’s unlikely he’d spend any time behind bars for a first-time conviction involving charges in the lowest tier of felonies. Because it is a state case, Trump would not be able to pardon himself once he returns to office. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Get local news delivered to your inbox!NoneFGIC Announces NYSDFS Approval of CPP Upward Adjustment

NoneWest Virginia State Football Championships: Laidley Field Ready for Epic WeekendRonald John Burris Sr., age 82, a resident of Colony, Kansas, surrounded by his daughters, passed away peacefully at his home Wednesday, Dec. 4, 2024. He was born April 16, 1942 in Hamilton, Kan., to John Peter Burris and Hazel Charlotte Uhl (Burris). Ronald completed the 8 grade and then went on to earn a GED for his school-aged years. Ronald graduated from Allen County Community College and majored in political science. He also earned a bachelor of science degree in Administration of Justice with a minor in pre-law from Wichita State University. As a young adult, Ronald proudly enlisted in the U.S. Army on May 28,1962 to go fight for our freedom in the Vietnam War. Ronald was very proud of his responsibilities during his time in the Army and made sure to let his kids and grandkids know he sat “door gunner” on the choppers during the war. Ronald served four years in the Army. He then reenlisted in the U.S. Navy where he proudly served in the Navy Seabees for 20 months. Ronald was a proud veteran and held it very near and dear to his heart. Ronald always took every opportunity he had to thank a service member or veteran for their service. Ronald was self-employed most of his life. Like his father, Ronald worked in the oil fields for over 40 years and became quite successful. It was his true passion, and he thoroughly enjoyed it. Ronald had a very full and adventurous life. He was an avid coin collector. He loved to buy and hunt for coins. He never spent any change in his pocket so he could look for unique and valuable coins. Ronald also loved going to the casino. He seemed to never lose any money. His trips were also extra special when he loaded up his beloved dog, Odie. He also enjoyed traveling, taking many frequent vacations alone and with his daughters. Ronald also had a love for Raiders football and rooted for a win every game. Ronald’s children and grandchildren were the light of his life. He thoroughly enjoyed every minute he had with them and treasured their close bond. He had four children and seven grandchildren who will love and miss him forever. Ronald is survived by his children, Kelsey Lampe (Levi), LaHarpe, Sara Burris (Charles Hon), Iola, and Kaci Peres (Zachery), Overland Park; two sisters, Melba Shields and Patricia Burris of Parsons; grandchildren, Cadin Peres, Maddilyn Peres, Isabella Peres, Asher Peres, Ellie Lampe, Emersyn Lampe, and Willow Peres; his dog, Odie, and many nieces, nephews, cousins and friends. Ronald was preceded in death by his parents; a son, Ronald John Burris Jr; a brother, Harvey Burris; two infant siblings, and his lifelong friend, Mick Winner. The family will greet family and friends from 5 to 7 p.m. Monday, Dec. 9 at Countryside Funeral Home in Chanute, followed by funeral services at 10 a.m. Monday, Dec. 16 at Fellowship Regional Church in Iola. Burial will take place at the Highland Cemetery in Iola with military honors. A highlight of Ronald’s life was participating in the Veterans Honor Flight. Memorial donations are suggested for the Southern Coffey Honor Flight and may be left with the funeral home. Funeral arrangements are entrusted to Countryside Funeral Home, 101 N. Highland, Chanute. Advertisement Advertisement

BILLERICA, Mass.--(BUSINESS WIRE)--Nov 22, 2024-- Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the “Notice”) on November 21, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q"), it is no longer in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice, or until January 20, 2025, to submit a plan to regain compliance with the Rule. On November 12, 2024, the Company previously announced that it would be delayed in filing the Form 10-Q due to the need to restate the Company’s audited consolidated financial statements as of December 31, 2023 and 2022 and for each of the three years in the period ended December 31, 2023, and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024 and June 30, 2024. The Notice from Nasdaq is standard practice in the event of a delayed periodic financial report filing and was anticipated. The Company is continuing to work expeditiously to complete the filing of the Form 10-Q and remains on track to complete the restatement and all required filings by the end of 2024. This announcement is made in compliance with Nasdaq Listing Rule 5250(b)(2). About Quanterix From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa ® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 3,100 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn . Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this press release are based on Quanterix’s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’s actual results to differ from those expressed or implied in the forward-looking statements in this press release include, but are not limited to, that the Company may have underestimated the scope and impact of the restatement of certain of its financial statement and the risk that the Company’s restated financial statements may take longer to complete than expected, as well as those described in our periodic reports filed with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241122959546/en/ CONTACT: Media: media@quanterix.comInvestor Relations: Amy Achorn (978) 488-1854 ir@quanterix.com KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH TECHNOLOGY HEALTH MEDICAL DEVICES SOURCE: Quanterix Corporation Copyright Business Wire 2024. PUB: 11/22/2024 05:00 PM/DISC: 11/22/2024 05:02 PM http://www.businesswire.com/news/home/20241122959546/enMan City: Pep Guardiola admits he's questioning himself as poor run continuesMiddle East latest: Israeli strikes on Gaza hospital wound 3, Netanyahu vows 'iron fist' in Lebanon

Previous: 48 jili

Next: jili games slot



  • This website reprints and indicates that the works are from other sources for the purpose of delivering more information. It does not mean that this website agrees with their views or confirms the authenticity of their content. We do not bear direct responsibility and joint liability for the infringement of such works. When other media, websites or individuals reprint from this website, they must retain the source of the works indicated by this website and bear the legal responsibilities such as copyright.
  • If there are any issues regarding the content, copyright, etc. of the work, please contact this website within one week from the date of publication of the work, otherwise it will be deemed as giving up the relevant rights.